Suppr超能文献

未破裂颅内动脉瘤显微手术夹闭术后的硬膜下积液及出血转化

Subdural hygroma and hemorrhagic conversion after microsurgical clipping for unruptured intracranial aneurysm.

作者信息

Han Hyun Jin, Kim Jung-Jae, Park Keun Young, Park Sang Kyu, Chung Joonho, Kim Yong Bae

机构信息

Department of Neurosurgery, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.

Department of Neurosurgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

Acta Neurochir (Wien). 2023 May;165(5):1251-1260. doi: 10.1007/s00701-023-05555-0. Epub 2023 Mar 17.

Abstract

BACKGROUND

Chronic subdural hematoma (cSDH) is a unique hemorrhagic complication associated with microsurgical clipping. We aimed to investigate the risk factors of subdural hygroma (SDG) formation and its hemorrhagic conversion to cSDH.

METHODS

We reviewed the medical records of 229 patients who underwent microsurgical clipping for unruptured intracranial aneurysms (UIA) from 2016 to 2019. Risk factors for SDG and cSDH formation were analyzed.

RESULTS

Male sex, age ≥ 60 years, higher degree of arachnoid dissection, severe brain atrophy, and a large volume of subdural fluid collection (SFC) before discharge were independent risk factors for SDG formation. The risk factors for hemorrhagic conversion from SDG were continuous use or early resumption of antiplatelet drugs (odds ratio (OR): 15.367, 95% CI: 1.172-201.402) and a larger volume of SFC before discharge (OR: 0.932, 95% CI: 0.886-0.980). In the early resumption group, antiplatelet drug was resumed at a mean duration of 7.48 days postoperatively, and hemorrhagic conversion was detected earlier than that in the late resumption or no-use groups (4.09 vs. 7.18 weeks, P = 0.046). Following the receiver operating characteristic analysis, the SFC cutoff volume for hemorrhagic conversion was determined to be 23.55 mL.

CONCLUSION

These findings can assist clinicians in identifying patients at a high risk of SDG and cSDH formation. Antiplatelet resumption and its timing should be determined with consideration of the risk of cSDH formation as well as individual medical conditions.

摘要

背景

慢性硬膜下血肿(cSDH)是一种与显微手术夹闭相关的独特出血性并发症。我们旨在研究硬膜下积液(SDG)形成及其出血转化为cSDH的危险因素。

方法

我们回顾了2016年至2019年因未破裂颅内动脉瘤(UIA)接受显微手术夹闭的229例患者的病历。分析了SDG和cSDH形成的危险因素。

结果

男性、年龄≥60岁、蛛网膜分离程度较高、严重脑萎缩以及出院前硬膜下积液量较大是SDG形成的独立危险因素。SDG出血转化的危险因素是持续使用或早期恢复抗血小板药物(比值比(OR):15.367,95%置信区间:1.172-201.402)和出院前较大的硬膜下积液量(OR:0.932,95%置信区间:0.886-0.980)。在早期恢复组中,抗血小板药物在术后平均7.48天恢复使用,出血转化的检测时间早于晚期恢复组或未使用组(4.09周对7.18周,P = 0.046)。经过受试者工作特征分析,确定出血转化的硬膜下积液临界体积为23.55 mL。

结论

这些发现有助于临床医生识别发生SDG和cSDH的高危患者。应综合考虑cSDH形成的风险以及个体医疗状况来确定抗血小板药物的恢复使用及其时机。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验